But it is a window into something larger: how misconfigured digital advertising campaigns can quietly drain public funds while delivering little public value
Why the BMI 30/27 Thresholds Exist The specific BMI thresholds arent arbitrary
The FDA significantly increased its compliance activity surrounding advertising for compounded drugs in 2025, and recent remarks from an FDA official highlighted the agencys concerns about claims that state or imply the equivalence of compounded drugs to approved drugs
WADA (World Anti-Doping Agency): IGF-1 and all analogs, including LR3, are prohibited substances under the S2 category (Peptide Hormones, Growth Factors, and Related Substances)
Start by discussing the details of your case with a defective drug attorney who can help you understand your legal rights
Diabetes UK: I Am the Director of My Diabetes After Agony of Misdiagnosis Children's Hospital of Philadelphia: Atypical Diabetes Cleveland Clinic: Brittle Diabetes UC Health: Is There a Gray Area Between Type 1 and Type 2 Diabetes
